Vertex Pharmaceuticals
Price & Volume
Stats
See more52W Range | $362.50-$507.92 |
Market Cap | $110.9B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $12.2B |
Revenue Growth (YoY) | 7.8% |
Gross Profit (12 Mos) | $6.6B |
Diluted EPS | $16.83 |
News
See moreYahoo Finance • yesterday
2 Healthcare Stocks with Exciting Potential and 1 Facing Challenges
Yahoo Finance • 3 days ago
Fortune Reveals the 100 Most Powerful Women in Business 2026 List
Yahoo Finance • 4 days ago
Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?
About
CEO | Dr. Reshma Kewalramani FASN, M.D. |
CFO | Mr. Charles F. Wagner Jr. |
Address | 50 Northern Avenue, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6,400 |